EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
SA and SK attended the EAAD 2018 which focused on the dissemination of new data collected by ECDC and OECD. SA made a brief statement during the event underlining the importance of stewardship teams that involve hospital pharmacists.
On 28th January, ECDC released a survey that aims at assessing healthcare workers’ antibiotic use and resistance. SA contributed to the design of the survey. The Policy Team alerted members in mid-January and shared the survey link with members on 28th January. The consultation period will end on 14th February. Board members are encouraged to respond.
EAHP officially joined the Stakeholder Forum of EU-JAMRAI. SA attended the 1st annual meeting of the initiative in early November. EAHP signed the Memorandum of Understanding in November and mailed it by post to the organisers. The copy has not yet been sent back to us.
EPHA’s AMR working group stared to operate in fall 2018 due to the addition of a new staff member. Ann Marie Borg primarily focused her activity on the collection of information on national AMR action plans. The results of this data collection activity will be shared with the public in early 2019. Also the activities of the thematic network on AMR were restarted with a meeting of interested parties that have signed the joint statement on AMR in early 2018. EPHA mainly used the event to obtain information from ‘national member associations’ on their AMR initiatives. In addition, extensive background information relating to the revision of national AMR action plans was shared by Ann Marie Borg.
SA, KN, NM and SK worked on the further development of the ‘EAHP opinion on pharmaceuticals in the environment. See document HERE
The Board should decide if EAHP should adopt an opinion on pharmaceuticals in the environment.
SA attended the kick-off meeting of ECRAID in mid-January.
EAHP endorsed the EU Influenza Manifesto. In early January 2019, SK and VD met with Hanover Consulting – the entity that runs the EU Influenza Manifesto – to obtain more information on the future plans of the initiative. EU Influenza Manifesto is planning to engage actively during the EU Influenza week in April 2019. NM has been encouraged to join the calls of the Steering Committee of the EU Influenza Manifesto from time-to-time to input on elements relevant to hospital pharmacy.
The endorsement should be publicised after the Board meeting. This could be linked to the publication of an EAHP opinion on vaccination (see below).
Given the Commission’s active engagement in the field of vaccination and the publication of Council Recommendations in December 2018, NM and SK worked on an ‘EAHP opinion on vaccination’. See document HERE
The Board should decide if EAHP should adopt an opinion on vaccination.
Ber Oomen has repeatedly turned down requests to meet with him (or other representatives of ESNO) to speak about ESNO’s activities in relation to AMR and vaccination.
In November 2018, ESNO published a position on AMR (see HERE). The statement advocates for a stronger involvement of nurses and announces the publication of an ‘Information and Communication Guide on AMR’ to ensure that nurses across Europe can access accurate, consistent information on drug resistance. The guide should be published in April 2020 and it will also address vaccination. A draft is expected to be produced by the working group in January 2019 (more information see HERE)
SK will attend ESNO’s Congress in February 2019 to obtain further information on ESNO activities since a bilateral meeting with Ber Oomen is not possible. In this regard, it should be noted that Ber initiated contact with EAHP, PGEU and EPF after the EAAD 2018 to discuss AMR. However, he never followed-up and confirmed a meeting date.
